Results 81 to 90 of about 2,260,600 (191)

DNA Methylation Epigenetically Regulates Gene Expression in Burkholderia cenocepacia and Controls Biofilm Formation, Cell Aggregation, and Motility

open access: yesmSphere, 2020
Respiratory tract infections by the opportunistic pathogen Burkholderia cenocepacia often lead to severe lung damage in cystic fibrosis (CF) patients.
Ian Vandenbussche   +5 more
doaj   +3 more sources

Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients

open access: yesCell Discovery, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic of Coronavirus disease 2019 (COVID-19). However, the microbial composition of the respiratory tract and other infected tissues as well as their possible pathogenic ...
Huanzi Zhong   +32 more
doaj   +1 more source

The detection of Burkholderia spp. and pathogenic Leptospira spp. in South Africa [PDF]

open access: yes, 2013
Leptospirosis is a zoonosis of ubiquitous distribution and causes a wide spectrum of disease. Burkholderia species are important plant and human pathogens.
Saif, Adrienne N.
core  

Biocatalysis as Useful Tool in Asymmetric Synthesis: An Assessment of Recently Granted Patents (2014–2019) [PDF]

open access: yes, 2019
The broad interdisciplinary nature of biocatalysis fosters innovation, as different technical fields are interconnected and synergized. A way to depict that innovation is by conducting a survey on patent activities.
Alcántara, Andrés R.   +2 more
core   +3 more sources

Defensin: The immune system regulatory factor against peripheral nerve disease

open access: yesBrain‐X, Volume 3, Issue 1, March 2025.
Peripheral nerve disease is a common disorder that can lead to sensory, motor, and autonomic dysfunction, with common symptoms including pain, loss of sensation, lack of coordination, muscle weakness, and atrophy. Defensins (which can be divided into mammal, insect, and plant defensins), as regulatory factors of the immune system, can influence ...
Tiantian Qi   +8 more
wiley   +1 more source

Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis [PDF]

open access: yes, 2013
Burkholderia cepacia complex organisms are important transmissible pathogens found in cystic fibrosis (CF) patients. In recent years, the rates of cross-infection of epidemic strains have declined due to effective infection control efforts.
Alexander   +47 more
core   +1 more source

Clinical Detection and Management of Colorectal Cancer Concerning the Gut Microbiome

open access: yesScientifica, Volume 2025, Issue 1, 2025.
Colorectal cancer (CRC) is a prevalent malignancy worldwide and a leading cause of cancer‐related mortality, influenced by both genetic predisposition and environmental factors. Gut dysbiosis, characterized by an imbalance in the gut microbiome, has been identified as a significant contributor to CRC progression. Although considerable progress has been
Hamed Eraghieh Farahani   +3 more
wiley   +1 more source

Cystic fibrosis year in review 2023

open access: yesPediatric Pulmonology, Volume 59, Issue 12, Page 3106-3116, December 2024.
Abstract This past year, there were many important advances for patients with cystic fibrosis (CF). Of the many publications related to CF in 2023, there was further evaluation of highly effective modulator therapy, new assessments and guidelines for clinical manifestations and therapies for CF, advances in newborn screening and diagnosis, and ...
David V. Swetland, Adrienne P. Savant
wiley   +1 more source

Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches

open access: yesFrontiers in Microbiology, 2017
Burkholderia cenocepacia is an opportunistic pathogen particularly dangerous for cystic fibrosis (CF) patients. It can cause a severe decline in CF lung function possibly developing into a life-threatening systemic infection known as cepacia syndrome ...
Viola C. Scoffone   +6 more
doaj   +1 more source

Cefiderocol utilization in lung transplant recipients at a single center

open access: yesTransplant Infectious Disease, Volume 26, Issue 4, August 2024.
A retrospective analysis of cefiderocol utilization in lung transplant recipients at a single center. This study highlights the primary indications, adverse effects, and mortality outcomes, among other measures, providing insight into its potential use in managing multidrug‐resistant infections in this population.
Purnadeo N. Persaud   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy